ÅǸ޴º
Á¦¸ñ | Moon YW*, An H-J*, Koo JS, et al.. CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator. (*Both equally contributed). Oncotarget 9: 2622-30; 2017 | µî·ÏÀÏ | 20190505 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Moon YW*, An H-J*, Koo JS, et al.. CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator. (*Both equally contributed). Oncotarget 9: 2622-30; 2017
|
Copyright ¨Ï chamc, All rights reserved.